Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Can-Fite BioPharma Ltd. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 14 | 8 | −6 |
| Shares | 138.3K | 50.2K | −88.1K (−63.7%) |
| Value | $428.6K | $149.1K | −$279.5K (−65.2%) |
New holders (0)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (6)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Sabby Management, LLC | 42,559 | $131.9K |
| HRT Financial LP | 19,383 | $60.0K |
| Virtu Financial LLC | 12,908 | $40.0K |
| Citigroup Inc | 5,482 | $17.0K |
| UBS Group AG | 2,152 | $6.67K |
| Advisor Group Holdings, Inc. | 450 | $1.40K |